Morgan Stanley
HURA

Morgan Stanley’s TuHURA Biosciences HURA Stock Holding History

Morgan Stanley’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Buy
143,257
+119,424
+501% +$278K ﹤0.01% 5730
2026
Q1 		$42.7K Sell
23,833
-152,364
-86% -$187K ﹤0.01% 6478
2025
Q4 		$133K Buy
176,197
+154,442
+710% +$296K ﹤0.01% 6082
2025
Q3 		$54K Sell
21,755
-12,366
-36% -$32.5K ﹤0.01% 6371
2025
Q2 		$76.1K Buy
34,121
+22,298
+189% +$75.3K ﹤0.01% 6222
2025
Q1 		$38.2K Buy
11,823
+6,985
+144% +$25.8K ﹤0.01% 6367
2024
Q4 		$19.8K Buy
4,838
+4,825
+37,115% +$25.7K ﹤0.01% 6575
2024
Q3 		$88 Buy
+13
New +$97 ﹤0.01% 7462
2023
Q4 		– Sell
-96
Closed -$13.5K – 7920
2023
Q3 		$13.5K Hold
96
– – ﹤0.01% 6614
2023
Q2 		$13.5K Hold
96
– – ﹤0.01% 6699
2023
Q1 		$11.8K Sell
96
-25
-21% -$4.82K ﹤0.01% 6826
2022
Q4 		$29.3K Buy
121
+120
+12,000% +$26.7K ﹤0.01% 6528
2022
Q3 		$0 Buy
+1
New +$320 ﹤0.01% 7914
2022
Q2 		– Sell
-3
Closed -$1.31K – 8015
2022
Q1 		$2K Sell
3
-2
-40% -$1.44K ﹤0.01% 7767
2021
Q4 		$4K Buy
5
+2
+67% +$2.7K ﹤0.01% 7701
2021
Q3 		$5K Hold
3
– – ﹤0.01% 7503
2021
Q2 		$13K Hold
3
– – ﹤0.01% 7161
2021
Q1 		$10K Buy
+3
New +$10.2K ﹤0.01% 6948
2020
Q4 		– Hold
0
– – – 7133
2020
Q3 		– Hold
0
– – – 6849
2020
Q2 		– Hold
0
– – – 6750
2020
Q1 		– Hold
0
– – – 6735
2019
Q4 		– Hold
0
– – – 6791
2019
Q3 		– Hold
0
– – – 6779
2019
Q2 		– Hold
0
– – – 6767
2019
Q1 		– Hold
0
– – – 6544
2018
Q4 		– Hold
0
– – – 6530

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley's HURA Position: Q2 2026 in Review

Morgan Stanley increased its TuHURA Biosciences (HURA) stake by 501% in Q2 2026, buying an estimated $278K and bringing the position to 143,257 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #5730.

Morgan Stanley first reported a position in HURA in Q1 2021 and has held it in 18 quarters since. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Morgan Stanley held 143,257 shares of TuHURA Biosciences worth $335K as of Q2 2026.
  • Morgan Stanley bought 119,424 TuHURA Biosciences shares in Q2 2026, an estimated $278K.
  • TuHURA Biosciences made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #5730 holding.
  • Morgan Stanley first reported a position in TuHURA Biosciences in Q1 2021 and has held it in 18 quarters since.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.